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menopausal women).(2) In a developing country, the following 
risk factors have been found to correlate with a higher pre-
valence of CAD: Age ≥55, typical angina, hypertension, diabetes 
mellitus and dyslipidaemia.(4) There are no published reports 
regarding prevalence of CAD in patients undergoing valve 
surgery in South Africa. We suspected that given our younger 
population with fewer CAD risk factors and predominantly 
rheumatic VHD, the prevalence of CAD would be low, and 
that perhaps not all patients with VHD over the age of 40 years 
INTRODUCTION
Current guidelines on angiography screening are based on the 
substantial burden of coronary artery disease (CAD) in patients 
presented for valve surgery seen in industrialised nations – with 
up to 40% prevalence of CAD, depending on the series and 
definitions of significant stenosis.(1-3) Screening is done for CAD 
with the goal of finding either surgically correctable coronary 
lesions that may be bypassed during the same surgery as the 
valve replacement or corrected percutaneously before surgery. 
According to the American College of Cardiology and American 
Heart Association (ACC/AHA) recommendations, screening 
coronary angiography to assess associated CAD should be 
considered in selected patients before cardiac surgery or 
transcatheter intervention for VHD (valvular heart disease).(2) 
Invasive selective coronary angiography remains the gold 
standard for obstructive coronary artery disease diagnosis. 
Coronary angiography is indicated before valve intervention in 
patients with symptoms of angina, objective evidence of 
ischaemia, decreased LV systolic function, history of CAD, or 
coronary risk factors (including men age >40 years and post-
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Background: The prevalence of coronary artery disease 
(CAD) amongst patients presented for valve surgery 
has important implications for routine angiography. 
Information on the frequency of CAD in predominantly 
black patients presented for valve surgery in South 
Africa has not been published. 
Methods: A retrospective, descriptive study of 116 
patients presented for valve surgery that underwent 
coronary angiography between 2010 and 2011 was 
performed. CAD was defi ned as stenosis of 70% or 
greater in one or more epicardial vessels or ≥50% in the 
left main coronary artery, as defi ned by quantitative 
coronary angiography.  
Results: Median age was 57.4 (IQR 43 - 67) years (56.9% 
females). Black patients represented 66.4%, whites 
19.8%, and, coloured and Indian patients 13.8%. Hyper-
tension and smoking were the most common cardio-
vascular risk factors (26.7% and 16.4% respectively). 
Diabetes mellitus, dyslipidaemia, chronic kidney disease 
and prior CAD occurred collectively in 15.5% of study 
subjects. HIV prevalence was 12%, half of whom were 
on antiretroviral therapy. An isolated valve lesion 
occurred in 69% of patients, with the remainder having 
2 or more lesions. The most common valve lesion was 
aortic stenosis (43.1%), followed by mitral stenosis 
(36.2%), aortic regurgitation (29.3%), mitral regurgita-
tion (25.9%) and tricuspid regurgitation (19%). The 
predominant aetiology was rheumatic heart disease 
(58.6%), followed by degenerative valve disease (24.1%). 
CAD was documented in 10 patients (8.6%), of whom 
8 had single vessel disease and 2 had double vessel 
disease. 
Conclusion: The low prevalence of CAD found in 
younger, asymptomatic black patients without cardio-
vascular risk factors referred for valve surgery, raises 
the question of whether routine pre-operative coronary 
angiography in this sub-group is appropriate.  
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need to undergo routine coronary angiography pre-operatively. 
Thus, we sought to study the prevalence of CAD in patients 
undergoing valve surgery at Chris Hani Baragwanath Hospital.
METHODS
A retrospective, descriptive study of all patients presented for 
valve surgery that underwent coronary angiography at Chris 
Hani Baragwanath Academic Hospital in South Africa between 
2010 and 2011, was performed. In keeping with ACC/AHA 
guidelines on valve disease, significant coronary artery disease 
was defined as stenosis of 70% of a major coronary artery or 
≥50% diameter left main stenosis on quantitative coronary 
angiography.(2) Data were subjected to descriptive statistical 
analysis using Microsoft Excel.
Permission to conduct the study was granted by the University 
of the Witwatersrand ethics committee (M161163).
RESULTS
One hundred and sixteen patients were included in this study. 
Median age of the population was 57.4 (IQR 43 - 67) years 
(56.9% females). Black patients represented 66.4% (77), while 
whites, coloured and Indian patients represented 19.8% (23), 
0.8% (9) and 0.6% (7) respectively. Hypertension and smoking 
were the most common risk factors (26.7% and 16.4%, 
respectively). Diabetes mellitus, dyslipidaemia, chronic kidney 
disease and prior coronary artery disease occurred in 15.5%. 
The remainder had no known risk factors. Angina was present 
in 18% (21) patients. All patients were New York Heart 
Association (NYHA) functional class II or more. NYHA II, III 
and IV patients were distributed as follows: 54%, 38.8% and 
0.7%, respectively. HIV prevalence was 12%; half of whom 
were on antiretroviral therapy. Mean left ventricular ejection 
fraction was 53.9 ± 12%. The most common valve lesion was 
aortic stenosis (43.1%), followed by mitral stenosis (36.2%), 
aortic regurgitation (29.3%), mitral regurgitation (25.9%) and 
tricuspid regurgitation (19%). A single valve lesion occurred in 
69% of patients – with the remainder having 2 or more lesions. 
The most common aetiology was rheumatic heart disease 
(58.6%), followed by degenerative valve disease (24.1%). Con-
genital valve disease, infective endocarditis and aneurysms of 
the ascending aorta, accounted for the remainder (17.2%). 
CAD was documented in only 10 patients (9%), of whom 8 
had single vessel disease and 2 had double vessel disease. All 
were greater than 55 years of age. None of the patients with 
rheumatic heart disease had CAD. Nine of the 10 patients had 
degenerative aortic stenosis. One patient with CAD had prior 
infective endocarditis of the mitral valve.
None were HIV-positive, only 4 had preceding angina, and 4 
patients had no risk factors for CAD. Only 1 black patient, aged 
67, had CAD.
DISCUSSION
The main finding of this study was that in a predominantly 
black population undergoing valve replacement surgery for 
rheumatic heart disease, the prevalence of CAD was low. 
Given that invasive diagnostic angiography is not a benign 
procedure, especially when performed by inexperienced oper-
ators, the procedure should be individualised. Age, symptoms 
and cardiovascular risk factors should be considered when 
assessing the need for diagnostic coronary angiography prior to 
valve surgery.
Data to support routine angiography for patients undergoing 
valve replacement surgery are scant. The AHA/ACC and ESC/
EACTS guidelines carry only level of evidence grade 1C.(2,5) 
There is no objective evidence supporting routine coronary 
angiography in patients undergoing valve replacements. The 
addition of coronary artery bypass grafting (CABG) to valve 
replacement is associated with a higher mortality rate.(2,6) Most 
data for routine angiography are extrapolated from patients 
with isolated stable CAD who have undergone coronary 
angiography.(7) Most of these studies used quantitative coronary 
angiography with variable cut-off points for severity, and few 
early studies evaluated target vessel ischaemia by either invasive 
or non-invasive methods. Further, in stable, low risk CAD 
optimal medical therapy and surgery have shown equivalent 
outcomes.(8) Additionally, CT coronary angiography has been 
shown to be a reliable, cost-effective, non-invasive imaging 
alternative.(7,8,10) If the expertise exists, CT coronary angiography 
is preferable to invasive coronary angiography, for screening 
purposes. An argument is made that the modest additional 
early post-operative mortality from doing a CABG during aortic 
valve replacement (AVR) surgery, is offset by an improvement 
in long-term morbidity and mortality. This is despite the absence 
of randomised control trials to address this question in AVR 
patients.(11,12) Furthermore, some studies have shown no dif-
ference in outcomes between those who are and are not 
subjected to a CABG.(12) In summary, subjecting patients to 
routine coronary angiography has not been shown to improve 
outcomes in patients undergoing valve replacement surgery.
It has been shown in several series that the prevalence of CAD 
in valve replacement candidates from developing countries is 
substantially lower than that in industrialised nations. Rates 
range from 10% - 19%, depending on the definition of a signi-
ficant stenosis, and these generally occur at an older age. The 
lower rates in developing countries are partly due to the greater 
contribution of rheumatic valvular heart disease, as noted in the 
current study.(13-17) Indeed, such series have advocated a more 
conservative screening policy of asymptomatic, low risk patients, 
suggesting age cut-offs beyond 55 years. It is also important to 
note that the morbidity and mortality rates related to both 
angiography and CABG are generally higher in developing 
nations, where expertise is not as readily available. Therefore, 
in developing countries with limited resources, the risk:benefit 
and cost:benefit ratios do not favour routine coronary angio-
graphic screening.(18)
In our study, the rates of signif icant stenosis on coronary 
angiography were exceedingly low as a whole (9%), but 
especially so in the black population where the rate of comorbid 
CAD was only 1.3%. In addition, no patient with CAD was 
younger than 55 years of age. Considering the low prevalence 
of CAD, questionable benefit of the procedure, high cost and 
potential harm, it is the authors’ opinion that in predominantly 
black patients from a developing country background, the use 
of coronary angiographic screening should be restricted to 
patients with symptoms of coronary artery disease or cardio-
vascular risk factors.
LIMITATIONS
The main limitations of the study were its retrospective design. 
We did not systematically document clinical characteristics of 
all patients that underwent valve surgery who did not undergo 
coronary angiography. Further, the sample size was too small to 
do draw any substantial statistical correlations due to the low 
rate of CAD in the population. The current study uses an 
angiographic cut-off of 70% as the level to define significant 
stenosis, whereas many of the quoted studies use more liberal 
cut-offs of 50% – making comparison more difficult. The findings 
of this study should not be extrapolated to any population 
other than developing sub-Saharan Africans, as the genetic 
diversity of other populations is likely to create differences in 
CAD incidence.
CONCLUSION
Amongst a predominantly black sub-Saharan African population, 
the prevalence of CAD in patients presented for valve surgery 
is exceptionally low. HIV did not appear to play a role in this 
study. For black patients scheduled to undergo valve replace-
ment surgery in developing countries, we suggest individualising 
the decision to perform screening coronary angiography, taking 
into account age, symptoms and cardiovascular risk factors.
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